Introduction:
 

Welcome to the Website of Albert Einstein Biodefense Proteomics Research Center. The Albert Einstein College of Medicine of Yeshiva University has been funded by the National Institute of Allergy and Infectious Diseases (NIH/NIAID contract HHSN266200400054C) to establish a center for identifying therapeutic targets in waterborne parasites by proteomics approaches.

This center (established by Dr. George Orr) under the leadership of Dr. Ruth Angeletti brings together Albert Einstein faculty with expertise in apicomplexan parasitology, proteomics and bioinformatics and includes Dr. Louis Weiss, Dr. Kami Kim, and Dr. Andras Fiser. These investigators will join to identify and validate potential targets, develop novel proteomic and bioinformatics strategies to further biodefense and biomedical research efforts, and provide information and unique resources to advance selection of therapeutic targets and design of strategies for disease intervention.

Our Center was featured in the 2008 winter edition of The Einstein journal.